Our Focus About Resources Insights Portfolio
Investor Login

Joystar Insights

Expert analysis on the markets and technologies shaping tomorrow’s investments.

Fintech

France Urges Euro Stablecoins to Break Dollar Dependency

PYMNTS · Apr 17, 2026

French Finance Minister Roland Lescure said Friday (April 17) that European banks should develop more euro-based stablecoins and tokenized deposits to reduce the continent’s reliance on non-European payment providers, Reuters reported Friday. In pre-recorded comments delivered at a cryptocurrency conference in Paris, Lescure said that the small volume of euro-pegged stablecoins compared to dollar-pegged […] The post France Urges Euro Stablecoins to Break Dollar Dependency appeared first o

Read Analysis →
Technology & AI

‘Tokenmaxxing’ is making developers less productive than they think

TechCrunch · Apr 17, 2026

There's a lot more code — but it's a lot more expensive and requires a lot more rewriting.

Read Analysis →
Finance

Some grocers are using AI to cut food waste and boost profit margins

CNBC Markets · Apr 17, 2026

Grocers turn to AI pricing to cut waste, protect margins and compete for deal-seeking shoppers—targeting dynamic pricing discounts.

Read Analysis →
VC & Startups

Sector Snapshot: Autonomous Vehicle Funding More Than Triples In 2026 To Hit Record Amount

Crunchbase News · Apr 17, 2026

Several multibillion-dollar megadeals drove a spike in first-quarter investment in autonomous vehicles, signaling that investors aren't just paying for research, but betting on companies that are ready to scale up and put their AI technology into actual cars people can buy or hail.

Read Analysis →
IPO

The IPO Buzz: Alamar Biosciences (ALMR) Upsizes IPO & Prices it at $17 – High End

IPO Scoop · Apr 17, 2026

Alamar Biosciences (ALMR) upsized its IPO at pricing – to 11.25 million shares – up from 9.38 million in the prospectus –  and priced its IPO at $17.00 – the high end of its range – to raise $191.25 million on Thursday night, April 16, 2026.  Alamar Biosciences’ stock shot up $5.00 to open at […]

Read Analysis →
Finance

Netflix stock sinks after streamer reiterates guidance, says Reed Hastings to exit board

CNBC Markets · Apr 17, 2026

Netflix beat expectations for Q1 revenue and reported a big jump in earnings per share thanks in part to a termination fee related to its proposed WBD deal.

Read Analysis →
IPO

The IPO Buzz: Kailera Therapeutics (KLRA) Upsizes IPO & Prices it at $16 – High End

IPO Scoop · Apr 16, 2026

Kailera Therapeutics (KLRA), a biotech targeting obesity, upsized its IPO at pricing to 39.06 million shares – up from 33.33 million in the prospectus – and priced the deal at $16.00 – the top of its $14.00-to-$16.00 range – to raise $624.96 million on Thursday night, April 16, 2026. Kailera Therapeutics’ stock is expected to […]

Read Analysis →
Finance

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

CNBC Markets · Apr 16, 2026

The CDC has been going through turmoil and several leadership shakeups under HHS Secretary Robert F. Kennedy Jr.

Read Analysis →
Finance

RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves

CNBC Markets · Apr 16, 2026

Hims may have a chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.

Read Analysis →
VC & Startups

Exclusive: GetWhys Raises $5.2M To Help Companies Like Intel And Verizon Better Understand Their Customers

Crunchbase News · Apr 16, 2026

GetWhys, a Boise, Idaho-based AI-powered customer intelligence platform, has raised $5.2 million in funding, it tells Crunchbase News exclusively.

Read Analysis →
VC & Startups

These 3 Charts Show How Venture Capital Has Concentrated At The Top In 2026

Crunchbase News · Apr 16, 2026

In the first quarter of 2026, a handful of large, well-funded AI companies, almost all based in the U.S., captured the vast majority of venture dollars, even as global startup deal count fell, Crunchbase data shows.

Read Analysis →
IPO

The IPO Buzz: Arxis (ARXS) Priced Upsized IPO at $28 – Top of Range – & It Flew on NASDAQ

IPO Scoop · Apr 16, 2026

Arxis (ARXS) upsized its IPO at pricing – to 40.5 million shares – up from 37.74 million in the prospectus – and priced its IPO at $28.00 – the top of its range – to raise $1.13 billion on Wednesday night, April 15, 2026. Shares of Arxis (ARXS) shot up $10.00 in their NASDAQ debut […]

Read Analysis →